人間の核異種生物受容体PXR: 誘導性乱交の構造的決定因子
R E Watkins1, G B Wisely, L B Moore
1Department of Biochemistry and Biophysics, School of Medicine, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, NC 27599, USA.
まとめ
ヒトの妊娠中のX受容体 (hPXR) 構造は,それが薬剤に結合する方法を明らかにし,危険な薬物相互作用を予測し,予防するための洞察を提供します. hPXR結合を理解することは,より安全な薬剤使用の鍵です.
科学分野:
- バイオケミストリー バイオケミストリー
- 薬理学 薬理学とは
- 構造生物学 構造生物学とは
背景:
- 人間の核孕婦X受容体 (hPXR) は,薬物の代謝と相互作用に不可欠です.
- xenobioticsによるhPXRの活性化は,サイトクロームP450-3Aの発現に影響する.
- hPXRの調節障害は,有害な薬物相互作用に寄与する.
研究 の 目的:
- hPXRにおけるリガンド結合の構造的基礎を解明する.
- hPXRが,キセノバイオティクスを認識し,それに反応する方法を理解する.
- 薬物相互作用の予測と緩和のための基盤を提供すること.
主な方法:
- X線結晶学を用いて,hPXRリガンド結合ドメインの構造を決定した.
- 構造は,アポ形式とSR12813.complexの両方で解決されました.
- 高解像度 (2.5および2.75アンストーム) の構造データを取得しました.
主要な成果:
- 結晶構造は,hPXR.のリガンド結合腔を明らかにしています.
- 薬剤SR12813は,空洞内の3つの異なる方向に結合することが観察されました.
- 水害性空洞内の少数の極性残基は,リガンド結合と活性化に影響を与えます.
結論:
- 構造的な洞察は,hPXRがさまざまな異種生物質を検出する方法を説明します.
- 特定された極性残留は,PXRの薬理学的活性化プロファイルにとって重要である.
- これらの発見は,薬物相互作用の予測と回避に役立ちます.
関連する概念動画
Mismatch Repair
Overview
Nucleotide Excision Repair
Overview
Nucleotide Excision Repair
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...


